CALASIA PHARMACEUTICALS, INC.

Basic Information

6330 Nancy Ridge Drive
SAN DIEGO, CA, 92121-3220

http://www.calasiapharma.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 831901231
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. Development of Flavivirus Antivirals Targeting Dengue Virus and WNV Protease

    Amount: $600,000.00

    DESCRIPTION provided by applicant Mosquito borne members of the Flavivirus family include four serotypes of dengue virus DENV and West Nile Virus WNV and are classified as re emerging pathog ...

    SBIR Phase I 2014 Department of Health and Human Services National Institutes of Health
  2. Discovery and Development of Novel Glucose Dependent Partial Glucokinase Activato

    Amount: $201,930.00

    DESCRIPTION (provided by applicant): Type 2 diabetes (T2DM) is a chronic metabolic disease that affects the quality and longevity of life. Currently it is estimated that about 246 million people world ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Selective and dual-acting Hsp90 and TRAP1 inhibitors

    Amount: $279,068.00

    DESCRIPTION (provided by applicant): Although the existing agents for treating cancer have shown promising results, the inherent genetic plasticity of the cancer cells continues to undermine the effic ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government